Noemi Giannini
Overview
Explore the profile of Noemi Giannini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
74
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pasqualetti F, Lombardi G, Gadducci G, Giannini N, Montemurro N, Feletti A, et al.
J Pers Med
. 2024 Sep;
14(9).
PMID: 39338153
Gliomas of the brainstem represent a small percentage of central nervous system gliomas in adults. Due to the proximity of the tumor to critical structures, radical surgery is highly challenging...
2.
Sarogni P, Frusca V, Zamborlin A, Giannini N, Menicagli M, Brancato L, et al.
ACS Appl Mater Interfaces
. 2024 Aug;
16(33):43272-43282.
PMID: 39126693
Head and neck squamous cell carcinomas are characterized by a high incidence of recurrence, especially in patients with locally advanced disease. Standard treatment strategies can be associated with severe side...
3.
Gonnelli A, Gerbe de Thore M, Ermini M, Frusca V, Zamborlin A, Signolle N, et al.
Adv Mater
. 2024 May;
36(28):e2400949.
PMID: 38761135
Cisplatin chemoradiotherapy (CRT) is the established standard of care for managing locally advanced human papillomavirus-positive head/neck carcinoma. The typically young patients may suffer serious and long-time side effects caused by...
4.
Giannini N, Gadducci G, Fuentes T, Gonnelli A, Di Martino F, Puccini P, et al.
Front Oncol
. 2024 Apr;
14:1373453.
PMID: 38655137
FLASH-radiotherapy delivers a radiation beam a thousand times faster compared to conventional radiotherapy, reducing radiation damage in healthy tissues with an equivalent tumor response. Although not completely understood, this radiobiological...
5.
Pasqualetti F, Gabelloni M, Faggioni L, Aquaro G, De Vietro F, Mendola V, et al.
J Clin Med
. 2024 Apr;
13(5).
PMID: 38592330
Clinical evidence suggests an association between comorbidities and outcome in patients with glioblastoma (GBM). We hypothesised that the internal carotid artery (ICA) calcium score could represent a promising prognostic biomarker...
6.
Gonnelli A, Sarogni P, Giannini N, Linsalata S, Di Martino F, Zamborlin A, et al.
Artif Cells Nanomed Biotechnol
. 2024 Feb;
52(1):122-129.
PMID: 38315518
Locally advanced head and neck squamous cell carcinoma (LA-HNSCC) is characterized by high rate of recurrence, resulting in a poor survival. Standard treatments are associated with significant toxicities that impact...
7.
Ursino S, Gadducci G, Giannini N, Gonnelli A, Fuentes T, Di Martino F, et al.
Front Oncol
. 2023 Nov;
13:1254601.
PMID: 37936603
Radiotherapy (RT) is performed in approximately 75% of patients with cancer, and its efficacy is often hampered by the low tolerance of the surrounding normal tissues. Recent advancements have demonstrated...
8.
Pasqualetti F, Miniati M, Gonnelli A, Gadducci G, Giannini N, Palagini L, et al.
Biology (Basel)
. 2023 Oct;
12(10).
PMID: 37887005
Despite countless papers in the field of radioresistance, researchers are still far from clearly understanding the mechanisms triggered in glioblastoma. Cancer stem cells (CSC) are important to the growth and...
9.
Hyperthermia Reduces Irradiation-Induced Tumor Repopulation in an In Vivo Pancreatic Carcinoma Model
Sarogni P, Zamborlin A, Mapanao A, Logghe T, Brancato L, van Zwol E, et al.
Adv Biol (Weinh)
. 2023 Mar;
7(10):e2200229.
PMID: 36861331
Pancreatic cancer has a poor prognosis due to its aggressive nature and ability to metastasize at an early stage. Currently, its management is still a challenge because this neoplasm is...
10.
Santi M, Frusca V, Ermini M, Mapanao A, Sarogni P, Gonnelli A, et al.
J Mater Chem B
. 2022 Dec;
11(2):325-334.
PMID: 36484416
Head and neck squamous cell carcinomas (HNSCCs) are a complex group of malignancies that affect different body sites pertaining to the oral cavity, pharynx and larynx. Current chemotherapy relies on...